SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — May 5, 2020
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: May 5, 2020 · CIK: 0001711786 · Accession: 0001213900-20-011027
AI Filing Summary & Sentiment
File numbers found in text: 333-237567
Show Raw Text
CORRESP
1
filename1.htm
Hoth Therapeutics, Inc.
1 Rockefeller Plaza, Suite 1039
New York, New York 10020
May 5, 2020
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Abby Adams
Re:
Hoth Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-237567
Ms. Adams:
Pursuant to Rule
461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics,
Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above
be accelerated so that it will become effective at 5:00 p.m., Eastern Time, on Wednesday, May 6, 2020, or as soon thereafter as
possible.
Please notify Richard
Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as
to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Respectfully,
HOTH THERAPEUTICS, INC.
By:
/s/ Robb Knie
Name:
Robb Knie
Title:
Chief Executive Officer